Glucokinase gene mutation in non-insulin-dependent diabetes mellitus (NIDDM), and secondary diabetes in Koreans.
- Author:
Jae Hyun NAM
1
;
Hyun Chul LEE
;
Youn Euy KIM
;
Suk Ho KWON
;
Yong Suk YOON
;
Suk Won PARK
;
Bong Su CHA
;
Young Jun WON
;
Young Duk SONG
;
Eun Jig LEE
;
Sung Kil LIM
;
Kyung Rae KIM
;
Kap Bum HUH
Author Information
1. Department of internal Medicine, Yonsei university College of medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
glucokinase;
non-insulin-dependent diabetes mellitus;
post-renal transplantation diabetes mellitus
- MeSH:
Allografts;
Codon;
Diabetes Mellitus;
Diabetes Mellitus, Type 2*;
Diabetes, Gestational;
DNA;
DNA, Single-Stranded;
Exons;
Female;
Glucokinase*;
Humans;
Insulin;
Introns;
Polymerase Chain Reaction;
Polymorphism, Single-Stranded Conformational;
Pregnancy
- From:Korean Journal of Medicine
1998;54(6):755-764
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: Mutations in the glucokinase (GCK) gene are considered a possible cause of maturity-onset diabetes of the young. The purpose of this study was to evaluate the contribution of this gene to the development of non insulin dependent diabetes mellitus (NIDDM), gestational diabetes mellitus (GDM) and post-renal transplantation diabetes mellitus (PTDM). METHOD: Identification of GCK mutation was attempted on 39 NIDDM patients, 2 GDM patients and 58 selected renal allograft recipients with PTDM and 45 normal controls. The exons in the GCK gene were examined by polymerase chain reaction (PCR), followed by analysis of single-stranded DNA conformational polymorphism (SSCP). The abnormal bands were also confirmed by DNA sequenc- ing analysis. The exons of affected family members were also investigated for mutations of the GCK gene. RESULTS: Two of the 58 PTDM patients (3.4%) were found to have GCK mutations. One had the mutation on exon 5 and the other on intron 7. One control subject had the mutation on intron 9. The mutation of exon 5 was identified as a substitution of CCT(proline) for CTT (leucine) at codon 164, which has not ever reported before. The family members of the PTDM patient with mutation of exon 5 were analyzed by PCR followed by SSCP, and two of them revealed the same mutation. The abnormal band on the SSCP analysis of exon 7 was identified as the insertion of base C/T at the 39th nucleotide in intron 7. Two family members of this patients also had same band on SSCP. The one mutation of 45 normal controls was CT located at the 8th nucleotide in intron 9, which was a common polymorphism. CONCLUSON: We found GCK mutations in subjects with PTDM and we speculate that these mutations may be one of the contributing cause of PTDM.
